Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Diagnostics and Research

Laboratory Corporation of America Holdings is a clinical laboratory company that offers clinical laboratory tests used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease. The Company develops specialty testing operations, such as oncology testing, HIV genotyping, and phenotyping, diagnostic genetics, and clinical trials.
Website: labcorp.com



Growth: Bad revenue growth rate -17.4%, there is slowdown compared to average historical growth rates -0.3%. The revenue growth dynamics is unstable Site traffic for the last 3 months showed a change of +3.8%

Profitability: LTM EBITDA margin is positive, +10.4%. On average the margin is decreasing unsteadily. Gross margin is normal, +25.1%. In the last quarter the company did not beat the estimated EPS, -3.5%. The company was ahead of estimated EPS in 80% of quarters (showing a gain of +$0.06 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 1.4%. Free cash flow yield 2.4% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 2.6% higher than minimum and 35.5% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 1.7x by EV / Sales multiple , the company can be 8.3% overvalued

Key Financials (Download financials)

Ticker: LH
Share price, USD:  (-0.2%)202.82
year average price 215.92  


year start price 230.25 2023-04-18

max close price 241.33 2023-06-30

min close price 197.69 2023-10-25

current price 202.82 2024-04-16
Common stocks: 92 699 997

Dividend Yield:  1.4%
FCF Yield LTM: 2.4%
EV / LTM EBITDA: 18.1x
EV / EBITDA annualized: 252.9x
Last revenue growth (y/y):  -17.4%
Last growth of EBITDA (y/y):  -90.3%
Historical revenue growth:  -0.3%
Historical growth of EBITDA:  -10.5%
EV / Sales: 1.9x
Margin (EBITDA LTM / Revenue): 10.4%
Fundamental value created in LTM:
Market Cap ($m): 18 801
Net Debt ($m): 5 433
EV (Enterprise Value): 24 234
Price to Book: 2.4x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-04-12Zacks Investment Research

Labcorp's (LH) At-Home Mpox Testing Kit Gets the FDA's EUA Nod

2024-04-09Zacks Investment Research

Labcorp's (LH) Strategic Alliances Aid Amid Macroeconomic Woes

2024-04-08Zacks Investment Research

Labcorp (LH) Extends MRD Clinical Research With New Launch

2024-04-02Zacks Investment Research

Here's Why Investors Should Retain Labcorp (LH) Stock for Now

2024-03-25Zacks Investment Research

Labcorp (LH) Boost Diagnostics Suite With New Biomarker Test

2024-03-15Zacks Investment Research

Labcorp (LH) Expands Strategic Alliances, Test Sales Fall

2024-03-12Zacks Investment Research

Are Investors Undervaluing Labcorp (LH) Right Now?

2024-03-08Zacks Investment Research

Labcorp (LH) Introduces Weight Loss Management Portfolio

2024-02-26Zacks Investment Research

Here's Why Investors Should Hold Labcorp (LH) Stock for Now

2024-02-23Zacks Investment Research

Is Labcorp (LH) Stock Undervalued Right Now?
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol LH LH LH LH LH LH
reportedCurrency USD USD USD USD USD USD
cik 920 148 920 148 920 148 920 148 920 148 920 148
fillingDate 2024-02-26 2023-10-30 2023-08-04 2023-05-04 2023-02-28 2022-11-01
acceptedDate 2024-02-26 15:35:03 2023-10-30 15:27:21 2023-08-04 15:39:06 2023-05-04 13:38:26 2023-02-28 14:06:04 2022-11-01 12:54:42
calendarYear 2023.000 2023.000 2023.000 2022.000 2022.000 2022.000
period Q3 Q2 Q1 Q4 Q4 Q3
revenue 3 033M 3 057M 3 034M 3 778M 3 674M 3 606M
costOfRevenue 2 271M 2 206M 2 192M 2 803M 2 704M 2 546M
grossProfit 762M 851M 842M 975M 970M 1 060M
grossProfitRatio 0.251 0.278 0.278 0.258 0.264 0.294
researchAndDevelopmentExpenses 0 0 0 0 0 0
generalAndAdministrativeExpenses 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 533M 526M 506M 554M 537M 510M
otherExpenses -74M 21M -17M 69M 61M 65M
operatingExpenses 533M 581M 557M 623M 597M 575M
costAndExpenses 2 804M 2 787M 2 749M 3 426M 3 302M 3 122M
interestIncome 6M 16M 0 0 0 0
interestExpense 49M 50M 50M 51M 49M 46M
depreciationAndAmortization 146M 146M 143M 162M 156M 155M
ebitda 376M 437M 412M 503M 530M 625M
ebitdaratio 0.124 0.143 0.136 0.133 0.144 0.173
operatingIncome 229M 252M 266M 341M 374M 469M
operatingIncomeRatio 0.076 0.083 0.088 0.090 0.102 0.130
totalOtherIncomeExpensesNet -376M 19M -30M -63M -330M -48M
incomeBeforeTax -147M 239M 205M 278M 45M 422M
incomeBeforeTaxRatio -0.048 0.078 0.068 0.074 0.012 0.117
incomeTaxExpense 20M 55M 50M 65M -32M 68M
netIncome -167M 183M 189M 213M 76M 353M
netIncomeRatio -0.055 0.060 0.062 0.056 0.021 0.098
eps -1.970 2.120 2.140 2.410 0.860 3.910
epsdiluted -1.970 2.110 2.120 2.390 0.860 3.900
weightedAverageShsOut 85M 87M 88M 88M 89M 90M
weightedAverageShsOutDil 85M 87M 89M 89M 89M 91M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Balance Sheet Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol LH LH LH LH LH LH
reportedCurrency USD USD USD USD USD USD
cik 920 148 920 148 920 148 920 148 920 148 920 148
fillingDate 2024-02-26 2023-10-30 2023-08-04 2023-05-04 2023-02-28 2022-11-01
acceptedDate 2024-02-26 15:35:03 2023-10-30 15:27:21 2023-08-04 15:39:06 2023-05-04 13:38:26 2023-02-28 14:06:04 2022-11-01 12:54:42
calendarYear 2023.000 2023.000 2023.000 2022.000 2022.000 2022.000
period Q3 Q2 Q1 Q4 Q4 Q3
cashAndCashEquivalents 537M 728M 1 931M 394M 430M 410M
shortTermInvestments 0 0 0 0 0 0
cashAndShortTermInvestments 537M 728M 1 931M 394M 430M 410M
netReceivables 2 099M 2 065M 2 043M 3 050M 3 017M 2 983M
inventory 475M 461M 488M 481M 471M 468M
otherCurrentAssets 655M 700M 660M 770M 707M 512M
totalCurrentAssets 3 765M 3 954M 5 121M 4 695M 4 625M 4 372M
propertyPlantEquipmentNet 2 912M 2 821M 2 762M 2 944M 2 956M 2 885M
goodwill 6 143M 6 332M 6 169M 8 116M 8 121M 8 218M
intangibleAssets 3 342M 3 276M 3 154M 3 912M 3 947M 3 808M
goodwillAndIntangibleAssets 9 485M 9 608M 9 323M 12 028M 12 068M 12 025M
longTermInvestments 27M 40M 67M 66M 66M 64M
taxAssets 418M 8M 6M 8M 8M 29M
otherNonCurrentAssets 119M 457M 426M 459M 433M 451M
totalNonCurrentAssets 12 960M 12 932M 12 585M 15 505M 15 530M 15 454M
otherAssets 0 0 0 0 0 0
totalAssets 16 725M 16 886M 17 706M 20 200M 20 155M 19 826M
accountPayables 828M 691M 713M 881M 935M 766M
shortTermDebt 1 172M 1 160M 463M 489M 493M 185M
taxPayables 128M 0 0 0 146M 0
deferredRevenue 422M 361M 350M 587M 582M 531M
otherCurrentLiabilities 804M 690M 658M 930M 1 069M 1 041M
totalCurrentLiabilities 3 225M 2 901M 2 183M 2 886M 3 079M 2 522M
longTermDebt 4 055M 5 170M 5 748M 5 803M 5 802M 6 086M
deferredRevenueNonCurrent 728M 0 0 0 736M 0
deferredTaxLiabilitiesNonCurrent 418M 500M 565M 737M 736M 673M
otherNonCurrentLiabilities 409M 423M 419M 414M -295M 5 730M
totalNonCurrentLiabilities 5 609M 6 093M 6 731M 6 954M 6 980M 7 212M
otherLiabilities 0 0 0 0 0 0
capitalLeaseObligations 728M 911M 867M 938M 955M 935M
totalLiabilities 8 835M 8 994M 8 914M 9 839M 10 059M 9 734M
preferredStock 0 0 0 0 0 0
commonStock 8M 8M 8M 8M 8M 8M
retainedEarnings 7 888M 8 070M 8 823M 10 730M 10 582M 10 845M
accumulatedOtherComprehensiveIncomeLoss -59M -209M -154M -444M -493M -761M
othertotalStockholdersEquity 38M 5M 94M 48M 0 0
totalStockholdersEquity 7 875M 7 873M 8 772M 10 342M 10 097M 10 092M
totalEquity 7 891M 7 893M 8 792M 10 342M 10 097M 10 092M
totalLiabilitiesAndStockholdersEquity 16 725M 16 886M 17 706M 20 200M 20 155M 19 826M
minorityInterest 16M 19M 20M 19M 0 0
totalLiabilitiesAndTotalEquity 16 725M 16 886M 17 706M 20 200M 20 155M 19 826M
totalInvestments 27M 40M 67M 66M 66M 64M
totalDebt 5 954M 6 330M 6 210M 6 291M 6 295M 6 271M
netDebt 5 417M 5 602M 4 280M 5 897M 5 865M 5 861M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Cash Flow Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol LH LH LH LH LH LH
reportedCurrency USD USD USD USD USD USD
cik 920 148 920 148 920 148 920 148 920 148 920 148
fillingDate 2024-02-26 2023-10-30 2023-08-04 2023-05-04 2023-02-28 2022-11-01
acceptedDate 2024-02-26 15:35:03 2023-10-30 15:27:21 2023-08-04 15:39:06 2023-05-04 13:38:26 2023-02-28 14:06:04 2022-11-01 12:54:42
calendarYear 2023.000 2023.000 2023.000 2022.000 2022.000 2022.000
period Q3 Q2 Q1 Q4 Q4 Q3
netIncome -167M 184M 155M 213M 76M 353M
depreciationAndAmortization 150M 146M 143M 166M 156M 157M
deferredIncomeTax -60M -34M 14M 2M 70M -16M
stockBasedCompensation 27M 34M 34M 41M 30M 36M
changeInWorkingCapital 225M -108M -107M -356M -20M -196M
accountsReceivables -5M -66M -100 000 -118M -36M 30M
inventory -10M 26M -20M -10M 2M -12M
accountsPayables 146M -28M -117M -56M 172M 3M
otherWorkingCapital 94M -40M 30M -172M -158M -218M
otherNonCashItems 405M 54M 113M 56M 340M 39M
netCashProvidedByOperatingActivities 580M 276M 351M 121M 654M 374M
investmentsInPropertyPlantAndEquipment -167M -105M -103M -94M -118M -104M
acquisitionsNet -155M -390M -141M -6M -149M -460M
purchasesOfInvestments -9M -10M 0 0 -11M -100 000
salesMaturitiesOfInvestments 165M 7M 0 0 5M 200 000
otherInvestingActivites -165M 10M -10M 100 000 200 000 -103M
netCashUsedForInvestingActivites -331M -488M -254M -100M -273M -563M
debtRepayment -390M -458M -892M -828M -787M 0
commonStockIssued -200 000 -900 000 27M 28M -101M 32M
commonStockRepurchased 9M -1 009M 2 501M 0 -300M -400M
dividendsPaid -61M -64M -65M -64M -64M -65M
otherFinancingActivites -5M 544M -26M 804M 880M -19M
netCashUsedProvidedByFinancingActivities -447M -988M 1 545M -61M -373M -452M
effectOfForexChangesOnCash 6M -3M 3M 3M 12M -17M
netChangeInCash -191M -1 203M 1 537M -36M 20M -659M
cashAtEndOfPeriod 537M 728M 1 931M 394M 430M 410M
cashAtBeginningOfPeriod 728M 1 931M 394M 430M 410M 1 069M
operatingCashFlow 580M 276M 351M 121M 654M 374M
capitalExpenditure -167M -105M -103M -94M -118M -104M
freeCashFlow 412M 171M 249M 27M 536M 270M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Earning call transcript

2023 q4
2024-02-15 ET (fiscal 2023 q4)
2023 q3
2023-10-26 ET (fiscal 2023 q3)
2023 q2
2023-07-27 ET (fiscal 2023 q2)
2023 q1
2023-04-25 ET (fiscal 2023 q1)
2022 q4
2023-02-16 ET (fiscal 2022 q4)
2022 q3
2022-10-27 ET (fiscal 2022 q3)
2022 q2
2022-07-28 ET (fiscal 2022 q2)
2022 q1
2022-04-28 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-02-15 11:56 ET
Labcorp Announces 2023 Fourth Quarter and Full Year Results
2024-02-01 12:00 ET
Labcorp Named One of the World's Most Admired Companies™ by FORTUNE® Magazine
2024-01-31 12:00 ET
Labcorp Launches New Test for Risk Assessment and Prognosis of Severe Preeclampsia in Pregnant Women
2024-01-16 11:58 ET
Labcorp to Announce Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
2024-01-12 11:57 ET
Labcorp Declares Quarterly Dividend
2024-01-10 13:02 ET
Labcorp and Hawthorne Effect Collaborate to Bring Clinical Trials Directly to Patients and Investigators in Local Communities
2024-01-02 12:00 ET
Labcorp to Speak at the 42nd Annual J.P. Morgan Healthcare Conference
2023-12-30 00:10 ET
Madryn Asset Management Highlights Increasing Public Shareholder Opposition to Value-Destructive SomaLogic Merger and Calls on Company to Make Additional Disclosures
2023-12-26 14:15 ET
Madryn Asset Management Releases Evidence That SomaLogic Ran a Flawed and Incomplete Review of Alternatives
2023-11-20 12:00 ET
Labcorp and Legacy Health Finalize Comprehensive Laboratory Relationship
2023-11-16 12:00 ET
Tigerlily Foundation and Labcorp Launch I AM INCLUDED Framework to Increase Clinical Trial Diversity, Accelerate Delivery of Innovative Cancer Treatments
2023-11-14 14:55 ET
Geneoscopy Signs Multi-Year Agreement with Labcorp to Distribute Noninvasive Multi-Target Stool RNA (mt-sRNA) Colorectal Cancer Screening Test
2023-11-08 12:00 ET
Ovia Health Unveils New Fertility and Family Building Benefit
2023-10-26 10:58 ET
Labcorp Announces 2023 Third Quarter Results
2023-10-12 10:56 ET
Labcorp Declares Quarterly Dividend
2023-10-11 12:30 ET
Labcorp Launches New Test to Accelerate Path to Diagnosis of Alzheimer's Disease
2023-10-04 20:25 ET
LABCORP AND BAYSTATE HEALTH ANNOUNCE STRATEGIC RELATIONSHIP FOR DIAGNOSTIC LABORATORY SERVICES
2023-09-29 10:57 ET
Labcorp to Announce Third Quarter Financial Results on October 26, 2023
2023-09-27 15:15 ET
Graves Gilbert, Circuit Clinical, and Labcorp Join Forces to Bring Clinical Trials to Patients across South Central Kentucky
2023-09-14 10:56 ET
Labcorp to Present Strategy, Business and Financial Outlook at Investor Day
2023-08-03 11:00 ET
Labcorp Forges Strategic Partnership with Tufts Medicine, Will Acquire Outreach Laboratory Business
2023-07-31 10:58 ET
Labcorp to Host Investor Day on September 14, 2023
2023-07-27 10:57 ET
Labcorp Announces 2023 Second Quarter Results
2023-07-24 20:27 ET
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
2023-07-24 11:22 ET
Labcorp OnDemand Offers Menopause Test to Consumers
2023-07-13 12:00 ET
Labcorp Finalizes Strategic Relationship with Jefferson Health
2023-07-13 10:58 ET
Labcorp Declares Quarterly Dividend
2023-07-11 11:00 ET
LABCORP AND LEGACY HEALTH AGREE TO COMPREHENSIVE LABORATORY RELATIONSHIP
2023-07-03 11:05 ET
Fortrea Launches as Leading, Global Contract Research Organization Positioned to Bring Life-Changing Therapies to Patients Faster
2023-07-03 10:57 ET
Labcorp Completes Spin-off of Fortrea
2023-06-29 11:03 ET
Labcorp to Announce Second Quarter Financial Results on July 27, 2023
2023-06-14 12:59 ET
Labcorp Awarded Forrester Research 2023 Customer Obsession Leadership Award
2023-06-12 22:30 ET
LABCORP ANNOUNCES PRICING OF FORTREA $570 MILLION NOTES OFFERING IN CONNECTION WITH ANTICIPATED FORTREA SPINOFF
2023-06-09 20:44 ET
Labcorp Announces Information in Connection with its Spin-off of Fortrea
2023-06-08 13:08 ET
Labcorp Announces Launch of Fortrea's Notes Offering in Connection with Anticipated Spinoff
2023-06-07 11:00 ET
Labcorp Appoints Dr. Paul Rothman to Board of Directors
2023-06-05 10:57 ET
Labcorp's Planned Spin-off, Fortrea, to Host 2023 Investor Day
2023-05-31 20:35 ET
Labcorp Plasma Focus™ Liquid Biopsy Test Now Available
2023-05-16 11:00 ET
Labcorp and Providence Expand Strategic Laboratory Relationship
2023-05-04 10:56 ET
LABCORP TO WEBCAST ITS ANNUAL MEETING OF SHAREHOLDERS
2023-05-03 12:00 ET
Forge Biologics and Labcorp Announce Strategic AAV Gene Therapy Development and Manufacturing Collaboration
2023-05-03 10:59 ET
LABCORP AND JEFFERSON HEALTH ANNOUNCE STRATEGIC LABORATORY RELATIONSHIP
2023-04-25 10:52 ET
Labcorp Announces 2023 First Quarter Results
2023-04-06 10:51 ET
LABCORP DECLARES QUARTERLY DIVIDEND
2023-04-03 12:00 ET
LABCORP EXPANDS ACCESS TO COLORECTAL CANCER SCREENING THROUGH PARTNERSHIP WITH THE CONFERENCE OF NATIONAL BLACK CHURCHES
2023-03-31 10:59 ET
LABCORP TO ANNOUNCE FIRST QUARTER FINANCIAL RESULTS ON APRIL 25, 2023
2023-02-22 14:00 ET
Ovia HealthTM Expands Digital Platform Capabilities to Include Menopause Tracking
2023-02-16 12:00 ET
Labcorp Announces 2022 Fourth Quarter and Full-Year Results
2023-02-09 12:00 ET
Labcorp Unveils New Name for Future Independent Clinical Development Business - Fortrea
2023-01-18 21:28 ET
Labcorp to Announce Fourth Quarter and Full Year 2022 Financial Results on February 16, 2023
2023-01-12 21:22 ET
Labcorp Declares Quarterly Dividend
2023-01-05 12:00 ET
Thomas Pike to Join Labcorp as President and Chief Executive Officer of Its Drug Development Clinical Development Business Unit
2023-01-03 21:29 ET
Labcorp to Speak at the 41st Annual J.P. Morgan Healthcare Conference
2022-12-08 21:30 ET
Labcorp Opens New Los Angeles Based Laboratory
2022-11-14 14:23 ET
Oracle Cerner Technology to Manage Hospital Labs in 10 States
2022-10-31 20:26 ET
Labcorp to Speak at the Credit Suisse 31st Annual Healthcare Conference
2022-10-27 11:00 ET
Labcorp Announces 2022 Third Quarter Results
2022-10-13 20:30 ET
Labcorp Appoints Google Cloud Executive Kirsten Kliphouse to Its Board of Directors
2022-10-12 20:45 ET
Labcorp Declares Quarterly Dividend
2022-10-03 11:08 ET
Labcorp Establishes Comprehensive Laboratory Relationship With Ascension
2022-09-27 11:00 ET
Labcorp to Announce Third Quarter Financial Results on October 27, 2022
2022-09-06 10:59 ET
Labcorp to Speak at the Baird 2022 Global Healthcare Conference
2022-08-23 20:30 ET
Labcorp Acquires Clinical Outreach Laboratory Services From RWJBarnabas Health
2022-08-09 10:50 ET
BD, Labcorp Collaborate to Develop Flow Cytometry-Based Companion Diagnostics for Matching Patients with Treatments
2022-07-28 11:00 ET
Labcorp Announces 2022 Second Quarter Results
2022-07-28 10:59 ET
Labcorp to Spin Off Clinical Development Business
2022-07-22 13:51 ET
Labcorp Earns Top Score on 2022 Disability Equality Index
2022-07-19 20:25 ET
New Labcorp Test Report Helps Identify Insect Stings and Improve Therapy Decisions to Combat Allergic Reactions
2022-07-18 20:30 ET
Labcorp Expands Automated Clinical Trial Kit Production Line at European Operations Center
2022-07-14 21:43 ET
Labcorp to Announce Second Quarter Financial Results on July 28, 2022
2022-07-14 20:30 ET
Labcorp Declares Quarterly Dividend
2022-07-13 11:00 ET
Labcorp Launches New Test to Identify and Confirm Neurodegenerative Disease
2022-07-11 20:30 ET
Labcorp Forms Strategic Partnership With MD Anderson Cancer Center Foundation Spain to Increase Access to Early Phase Oncology Clinical Trials
2022-07-06 11:00 ET
Labcorp First National Laboratory to Offer Monkeypox Test
2022-06-28 20:15 ET
Labcorp Plans Laboratory Expansion in Japan Through BML Collaboration
2022-06-24 10:53 ET
 Tigerlily Foundation and Labcorp Collaborate to Increase Clinical Trial Diversity for Women of Color
2022-06-21 11:09 ET
Labcorp Enhances Clinical Trial and Drug Development Capabilities Through Real World Data Collaboration With HealthVerity
2022-06-02 21:19 ET
Labcorp Expands Access to Comprehensive Genomic Testing Through New Lung Cancer Program
2022-05-18 20:30 ET
Labcorp Launches New Test for People With Skin Cancer
2022-05-18 10:39 ET
Labcorp Receives Emergency Use Authorization for First Non-Prescription At-Home Collection Kit for Combined COVID-19, Flu and RSV Detection
2022-05-17 16:01 ET
Labcorp to Speak at the UBS 2022 Global Healthcare Conference
2022-05-16 20:30 ET
Labcorp Launches First-of-its-kind At-home Collection Device for Diabetes Risk Testing
2022-05-09 10:39 ET
Labcorp Acquires Diagnostic Clinical Laboratory Services From AtlantiCare
2022-05-04 17:30 ET
Labcorp to Webcast Its Annual Meeting of Shareholders
2022-04-28 10:53 ET
Labcorp Announces 2022 First Quarter Results
2022-04-22 14:51 ET
Labcorp Launches Convenient Home Diagnostic Test Collection Service in Collaboration With Getlabs
2022-04-19 20:30 ET
Labcorp Enhances Cell and Gene Therapy Development Support Through Collaboration With Xcell Biosciences
2022-04-07 10:57 ET
Labcorp Initiates Quarterly Dividend
2022-03-28 20:18 ET
Labcorp to Announce First Quarter Financial Results on April 28, 2022
2022-03-17 11:30 ET
New Labcorp Offering Makes Detecting, Measuring Unintentional Gluten Consumption Simple and Effective
2022-03-09 13:11 ET
Labcorp Enters Into Strategic Relationship With Prisma Health
2022-03-07 19:00 ET
Walgreens and Labcorp Offer At-Home COVID-19 PCR Test Collection Kits At No Cost Nationwide
2022-02-21 11:55 ET
Labcorp Completes Acquisition of Personal Genome Diagnostics
2022-02-10 12:08 ET
Labcorp Announces 2021 Fourth Quarter and Full-Year Results
2022-02-09 21:55 ET
Labcorp Enters Comprehensive, Long-Term Laboratory Relationship With Ascension
2022-02-07 12:30 ET
Labcorp Opens New Laboratory in South Bend, Expanding Services and Access in the Midwest
2022-02-04 12:13 ET
Labcorp Launches Labcorp OnDemand Digital Health Platform
2022-02-02 21:30 ET
Labcorp Named to Fortune® Magazine’s 2022 ‘World’s Most Admired Companies’ List for the Fourth Time
2022-01-27 21:15 ET
Labcorp Earns 100% on Human Rights Campaign Foundation’s Annual Scorecard on LGBTQ+ Workplace Equality
2022-01-26 14:00 ET
Labcorp to Offer Risk-Scoring Test for People With Advanced Liver Fibrosis Due to NASH
2022-01-26 13:50 ET
Siemens Healthineers Launches Enhanced Liver Fibrosis (ELF) Test in the U.S.
2022-01-12 15:00 ET
GenomOncology Pathology Workbench to Support OmniSeq INSIGHT℠, a Genomic and Immune Profiling Test That Identifies Potential Treatment and Clinical Trial Options for Solid Tumors
2022-01-10 21:32 ET
Labcorp to Announce Fourth Quarter and Full Year 2021 Financial Results on February 10, 2022
2022-01-04 21:29 ET
Labcorp to Speak Virtually at the 40th Annual J.P. Morgan Healthcare Conference
2021-12-23 12:09 ET
Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics, a Provider of Comprehensive Liquid Biopsy and Tissue-Based Genomic Products and Services
2021-12-09 11:58 ET
Labcorp Announces Initiatives to Enhance Shareholder Value
2021-12-03 17:34 ET
Labcorp Completes Acquisition of Toxikon Corporation
2021-12-01 12:21 ET
Labcorp and ConcertAI Optimize Precision Oncology Research With Real-World Data and Artificial Intelligence
2021-11-30 12:03 ET
Labcorp Now Offers Observed Collection for COVID-19 PCR Testing in Over 500 Locations Nationwide, With Plans to Expand to More Than 1,000 Locations
2021-11-18 12:09 ET
Labcorp to Acquire Toxikon, Expanding Nonclinical Development Testing Capabilities for Pharmaceutical, Biotech and Medical Device Clients
2021-11-04 21:57 ET
Labcorp and National Kidney Foundation Promote Patient Registry to Enhance Clinical Trial Accessibility, Diversity
2021-11-02 20:36 ET
Labcorp to Speak at Credit Suisse 30th Annual Healthcare Conference
2021-11-01 14:01 ET
Dr. Marcia Eisenberg, Labcorp Diagnostics Chief Scientific Officer, Named to Fierce Healthcare’s 2021 Women of Influence
2021-10-28 10:59 ET
Labcorp Announces 2021 Third Quarter Results
2021-10-14 12:00 ET
Pillar Biosciences to Collaborate with Labcorp on Precision Genomic Cancer Testing Using Next-Generation Sequencing
2021-10-01 14:12 ET
Labcorp Receives Emergency Use Authorization for At Home Collection Kit for Combined COVID-19 and Flu Detection
2021-09-28 20:18 ET
Labcorp to Announce Third Quarter Financial Results on October 28, 2021
2021-09-13 20:35 ET
Labcorp Completes Acquisition of Myriad Autoimmune’s Vectra Testing Business
2021-09-08 20:12 ET
Labcorp to Speak at Morgan Stanley 19th Annual Global Healthcare Conference
2021-09-02 20:33 ET
Labcorp Raises Minimum Hourly Wage to $15 Per Hour
2021-08-19 20:37 ET
Labcorp and Community Clinical Oncology Research Network Collaborate to Assess Social and Economic Impacts of Disparities in Cancer Care
2021-08-12 20:19 ET
Labcorp Extends Leadership in Women’s Health With Acquisition of Ovia Health
2021-08-05 11:15 ET
National Kidney Foundation and Labcorp Data Show Millions Aren't Tested for Kidney Disease
2021-07-29 11:01 ET
Labcorp Announces 2021 Second Quarter Results
2021-07-02 10:59 ET
Labcorp to Announce Second Quarter Financial Results on July 29, 2021
2021-07-01 21:03 ET
Labcorp Launches Companion Diagnostic for Amgen’s Newly-approved Lung Cancer Therapy
2021-06-22 12:28 ET
Labcorp Adopts Molecular Loop SARS-CoV-2 Research Sequencing Panel for Large-Scale Viral Surveillance
2021-06-14 15:11 ET
Labcorp And OmniSeq Launch INSIGHT℠, Next-Generation Sequencing Platform to Advance Precision Oncology
2021-06-08 20:35 ET
Pixel by Labcorp® COVID-19 PCR Test Home Collection Kits Now Available Nationwide at Walgreens and Through On-Demand Delivery
2021-06-02 21:20 ET
Labcorp to Introduce Combined Oncology Offering at 2021 ASCO® Annual Meeting
2021-05-24 21:14 ET
Labcorp Study Suggests COVID-19 Antibodies Remain at Least 10 Months After Infection
2021-05-19 21:54 ET
Labcorp to Expand Bioanalytical Services With Integrated Laboratory in Singapore
2021-05-18 10:59 ET
Labcorp to Speak at UBS Global Healthcare Virtual Conference
2021-05-13 12:57 ET
Pixel by Labcorp COVID-19 PCR Test Home Collection Kit Receives FDA Emergency Authorization for Ages 2-17
2021-05-13 00:14 ET
Labcorp Prices $500,000,000 in 1.550% Senior Notes Due 2026 and $500,000,000 in 2.700% Senior Notes Due 2031
2021-05-12 10:57 ET
Labcorp Announces Proposed Sale of Senior Notes
2021-05-11 20:18 ET
Labcorp and the U.S. Department of Health and Human Services Join Forces to Raise Awareness of COVID-19 Treatments
2021-05-03 10:58 ET
Labcorp to Acquire Myriad Autoimmune’s Vectra Testing Business From Myriad Genetics
2021-04-29 10:56 ET
Labcorp Announces 2021 First Quarter Results
2021-04-20 20:13 ET
Labcorp Launches COVID-19 Test Kits for Small Businesses to Support Return to Work and Life Safely
2021-04-16 11:01 ET
Labcorp to Webcast Its Annual Meeting of Shareholders
2021-03-30 20:30 ET
Labcorp to Announce First Quarter Financial Results on April 29, 2021
2021-03-26 10:57 ET
Labcorp Appoints Johnson & Johnson Executive Kathryn Wengel to the Board of Directors
2021-03-25 10:59 ET
Labcorp Lays out Priorities and Progress in Corporate Responsibility Report
2021-03-23 21:00 ET
Labcorp Business Update
2021-03-23 15:02 ET
Dr. Marcia Eisenberg, Chief Scientific Officer of Labcorp Diagnostics, Named a Healthcare Businesswoman’s Association Luminary
2021-03-19 10:58 ET
Labcorp Scheduled to Speak at KeyBanc Capital Markets' Life Sciences and MedTech Investor Forum
2021-03-10 12:01 ET
Circle Medical to Offer Labcorp’s At Home COVID-19 Self-Collection Test and Announces Clinical Expansion to Austin and San Diego Markets
2021-03-09 12:34 ET
Labcorp Named to Fast Company’s List of the World’s Most Innovative Companies for 2021
2021-03-03 13:00 ET
TrakCel Fuels Growth and Increased Market Access Through Strategic Investment Round
2021-02-24 18:00 ET
Walgreens to Make Pixel by Labcorp™ COVID-19 PCR Test Home Collection Kit Available Over-The-Counter at Stores Nationwide
2021-02-23 14:15 ET
Adaptive Biotechnologies Expands Collaboration with Labcorp to Increase Access to Growing Research and Clinical Diagnostic Portfolio
2021-02-23 11:54 ET
Labcorp is Scheduled to Speak at Citi's 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference
2021-02-18 13:01 ET
Pacific Biosciences Sequel II Systems Deployed to Scale-Up Global Viral Surveillance Initiatives Focused on COVID-19
2021-02-17 11:57 ET
Labcorp Adds High Sensitivity Antigen Test to Screen for Active COVID-19 Infection
2021-02-16 17:59 ET
Amy Summy, Chief Marketing Officer of Labcorp, Named to Forbes’ CMO Next
2021-02-11 11:58 ET
Labcorp Announces 2020 Fourth Quarter and Full Year Results and Provides 2021 Guidance
2021-02-09 16:02 ET
Labcorp Announces Key Appointments to Oncology Leadership Team
2021-02-01 20:39 ET
Labcorp Named to FORTUNE® Magazine’s 2021 ‘World’s Most Admired Companies,’ Making the Annual List for the Third Time
2021-01-28 16:28 ET
Labcorp Earns 100 Percent on Human Rights Campaign Foundation’s Annual Scorecard on LGBTQ Workplace Equality
2021-01-19 12:00 ET
Labcorp Appoints Dr. Deborah Ann Sesok-Pizzini as Chief Medical Officer, Labcorp Diagnostics
2021-01-08 11:57 ET
Labcorp to Announce Fourth Quarter and Full Year 2020 Financial Results on February 11, 2021
2021-01-07 21:20 ET
Labcorp Awarded CDC Contract to Study Variants of COVID-19 Virus and Improve Public Health Response
2021-01-06 12:40 ET
Brian Caveney, Chief Medical Officer and President of Labcorp Diagnostics, Named to Modern Healthcare's 100 Most Influential People in Healthcare
2021-01-05 11:59 ET
Labcorp Is Scheduled to Virtually Participate at the 39th Annual J.P. Morgan Healthcare Conference
2020-12-21 11:57 ET
Walgreens and Labcorp Make Pixel by Labcorp™ At-Home COVID-19 Collection Kit Available Through Walgreens Find Care®
2020-12-09 22:57 ET
LabCorp Receives FDA Authorization to Make At-Home COVID-19 Collection Kits Available Through Retail
2020-11-25 11:56 ET
LabCorp Is Scheduled to Present at The 2020 Evercore ISI 3rd Annual HealthCONx Conference
2020-11-20 13:55 ET
Circuit Clinical®, LabCorp, and Riverside Medical Group Collaborate to Expand Clinical Trial Access in New Jersey
2020-11-17 13:00 ET
Leading Diagnostics Companies Join Forces to Establish the Access to Comprehensive Genomic Profiling Coalition (ACGP)
2020-11-02 11:58 ET
LabCorp Is Scheduled to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference
2020-10-27 10:45 ET
LabCorp Announces 2020 Third Quarter Results
2020-10-20 10:58 ET
LabCorp Transforms the Clinical Trial Experience And Streamlines the Drug Development Process
2020-10-19 20:20 ET
LabCorp and Swedish Extend Laboratory Services Relationship, Providing Continued Access to High-Quality Diagnostics and COVID-19 Testing
2020-10-19 10:56 ET
LabCorp Launches Quantitative Antibody Test to Assess Effectiveness of COVID-19 Vaccines in Clinical Trials
2020-10-13 11:33 ET
LabCorp Is First to Provide Consumers With Secure Access to Their Diagnostic Test Results Through CommonHealth
2020-10-09 10:57 ET
LabCorp and HealthEC Launch Transformative Oncology Care Module
2020-10-05 10:58 ET
CLEAR Adds LabCorp COVID-19 Test Results to “Health Pass” Mobile App
2020-10-02 10:55 ET
LabCorp COVID-19 Molecular Test Innovation Receives FDA Authorization
2020-09-29 10:58 ET
LabCorp and Infirmary Health Form Strategic Partnership to Provide Laboratory Services Across Healthcare System
2020-09-28 20:22 ET
LabCorp to Announce Third Quarter Financial Results on October 27, 2020
2020-09-23 10:56 ET
New Non-Invasive Test for Lung Cancer Available Exclusively from LabCorp
2020-09-16 10:58 ET
Tempus and LabCorp Announce Collaboration to Accelerate Clinical Trial Patient Participation
2020-09-08 11:24 ET
LabCorp Launches First Combined Test for Covid-19, Flu and RSV in Time for Flu Season
2020-09-01 20:23 ET
LabCorp Is Scheduled to Present at the Baird’s 2020 Global Healthcare Conference
2020-08-11 11:00 ET
LabCorp Will Perform Antibody Test at No Charge to Accelerate COVID-19 Blood Plasma Donation
2020-07-30 19:26 ET
LabCorp Working With Public Health Authorities on No-Charge Antibody Test Program to Accelerate COVID-19 Blood Plasma Donation
2020-07-28 10:49 ET
LabCorp Announces 2020 Second Quarter Results
2020-07-25 14:14 ET
LabCorp Receives Authorization for COVID-19 Sample Pooling
2020-07-09 11:04 ET
LabCorp’s Insight Analytics Reports Help Healthcare Organizations Identify Trends for High-Risk Health Conditions and Improve Quality of Care
2020-07-07 11:58 ET
LabCorp Launches First Digital COVID-19 Service That Improves the Doctor and Patient Experience
2020-07-06 20:25 ET
LabCorp to Announce Second Quarter Financial Results on July 28, 2020
2020-06-29 11:01 ET
LabCorp Introduces Xcellerate® COVID-19 Clinical Study Solution
2020-06-25 10:56 ET
LabCorp Launches New Neutralizing Antibody Test
2020-06-01 10:59 ET
LabCorp Launches New COVID-19 Clinical Trial Site to Connect Patients With U.S. Research Trials
2020-05-28 10:55 ET
LabCorp Accelerates Adoption of Decentralized Clinical Trials, Expands Technology Ecosystem Through Alliance With Medable
2020-05-14 10:57 ET
LabCorp Launches Return to Work Services for Employers
2020-05-12 11:35 ET
LabCorp Significantly Expands Availability of Its COVID-19 At-Home Collection Test Kit
2020-05-06 10:54 ET
LabCorp Is Scheduled to Present at the Bank of America Securities 2020 Health Care Conference
2020-05-05 21:04 ET
COVID-19 Antibody Test Now Directly Available Through LabCorp.com
2020-05-05 10:53 ET
LabCorp to Webcast Its Annual Meeting of Shareholders
2020-04-29 10:53 ET
LabCorp Announces 2020 First Quarter Results
2020-04-27 20:12 ET
LabCorp COVID-19 Antibody Tests Available Nationwide With No Upfront Out-of-Pocket Costs
2020-04-22 10:48 ET
LabCorp Broadens Availability of COVID-19 Serological Antibody Tests to Hospitals, Healthcare Organizations and Through Its Patient Service Centers
2020-04-21 10:53 ET
LabCorp COVID-19 At-Home Test Kit Receives FDA Emergency Use Authorization
2020-04-09 11:01 ET
LabCorp and Ciox Health Enter Collaboration to Create Comprehensive Patient Data Registry
2020-04-06 10:52 ET
LabCorp to Announce First Quarter Financial Results on April 29, 2020
2020-03-23 13:07 ET
LabCorp Developing Options to Prioritize COVID-19 Testing for Inpatient Population in Support of Guidance from the White House Coronavirus Task Force
2020-03-19 19:01 ET
LabCorp Sets Dedicated Hours to Serve the Non-COVID-19 Testing Needs for Elderly and Most Vulnerable People
2020-03-05 20:43 ET
LabCorp Launches Test for Coronavirus Disease 2019 (COVID-19)
2020-03-02 21:35 ET
LabCorp Is Scheduled to Present at the 2020 Barclays Global Healthcare Conference
2020-02-13 11:57 ET
LabCorp Announces 2019 Fourth Quarter and Full Year Results and Provides 2020 Guidance
2020-01-21 14:46 ET
LabCorp Earns 100 Percent on Human Rights Campaign Foundation’s Annual Scorecard on LGBTQ Workplace Equality
2020-01-14 11:39 ET
LabCorp to Adopt Thermo Fisher Scientific’s Ion Torrent Genexus Next-Generation Sequencing System and Pan-Cancer Assay for Use in Oncology Research and Development
2020-01-13 22:10 ET
LabCorp to Announce Fourth Quarter and Full Year 2019 Financial Results on February 13, 2020
2020-01-06 11:19 ET
LabCorp is Scheduled to Present at the 38th Annual J.P. Morgan Healthcare Conference
2019-12-18 21:55 ET
LabCorp and Covance Connect Sponsors with Patients Virtually with an Expanded Suite of Decentralized Trial Solutions
2019-12-03 21:50 ET
LabCorp Announces Pricing Terms of Its Tender Offer for up to $300,000,000 Principal Amount of Its Outstanding 4.625% Senior Notes Due 2020
2019-12-03 13:45 ET
LabCorp Announces Early Results of Its Tender Offer for up to $300,000,000 Principal Amount of Its Outstanding 4.625% Senior Notes Due 2020
2019-11-26 13:30 ET
LabCorp Appoints Senior Finance Executive Jeffrey A. Davis to Its Board of Directors
2019-11-19 13:45 ET
Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021
2019-11-18 23:45 ET
LabCorp Prices $400,000,000 in 2.300% Senior Notes Due 2024 and $650,000,000 in 2.950% Senior Notes Due 2029
2019-11-18 13:56 ET
LabCorp Announces a Tender Offer for up to $300,000,000 Principal Amount of Its Outstanding 4.625% Senior Notes Due 2020
2019-11-18 13:50 ET
LabCorp Announces Proposed Sale of Senior Notes
2019-11-06 11:58 ET
LabCorp Announces Departure of John Ratliff, Names New LabCorp Diagnostics Leadership

SEC forms

Show financial reports only

SEC form 10
2024-02-26 00:00 ET
Laboratory of America published news for 2023 q4
SEC form 8
2024-02-15 00:00 ET
Laboratory of America reported for 2023 q4
SEC form 8
2024-02-15 00:00 ET
Laboratory of America published news for 2023 q4
SEC form 10
2023-10-30 00:00 ET
Laboratory of America published news for 2023 q3
SEC form 8
2023-10-26 07:05 ET
Laboratory of America reported for 2023 q3
SEC form 10
2023-08-04 00:00 ET
Laboratory of America published news for 2023 q2
SEC form 6
2023-07-27 07:04 ET
Laboratory of America reported for 2023 q2
SEC form 8
2023-07-27 00:00 ET
Laboratory of America published news for 2023 q2
SEC form 6
2023-07-13 07:15 ET
Laboratory of America published news for 2023 q2
SEC form 6
2023-07-07 15:05 ET
Laboratory of America published news for 2023 q2
SEC form 6
2023-07-03 07:10 ET
Laboratory of America published news for 2023 q2
SEC form 6
2023-06-29 07:31 ET
Laboratory of America published news for 2023 q1
SEC form 6
2023-06-12 17:29 ET
Laboratory of America published news for 2023 q1
SEC form 6
2023-06-09 17:05 ET
Laboratory of America published news for 2023 q1
SEC form 6
2023-06-08 09:11 ET
Laboratory of America published news for 2023 q1
SEC form 6
2023-06-07 07:50 ET
Laboratory of America published news for 2023 q1
SEC form 10
2023-05-04 00:00 ET
Laboratory of America published news for 2023 q1
SEC form 8
2023-04-25 00:00 ET
Laboratory of America reported for 2023 q1
SEC form 6
2023-04-06 08:02 ET
Laboratory of America published news for 2023 q1
SEC form 6
2023-03-31 08:37 ET
Laboratory of America published news for 2022 q4
SEC form 10
2023-02-28 14:06 ET
Laboratory of America reported for 2022 q4
SEC form 10
2023-02-28 00:00 ET
Laboratory of America reported for 2022 q4
SEC form 6
2023-02-16 07:03 ET
Laboratory of America published news for 2022 q4
SEC form 8
2023-02-16 00:00 ET
Laboratory of America reported for 2022 q4
SEC form 6
2023-01-18 16:32 ET
Laboratory of America published news for 2022 q4
SEC form 6
2023-01-12 16:26 ET
Laboratory of America published news for 2022 q4
SEC form 6
2023-01-05 07:10 ET
Laboratory of America published news for 2022 q4
SEC form 6
2023-01-03 16:34 ET
Laboratory of America published news for 2022 q4
SEC form 10
2022-11-01 12:54 ET
Laboratory of America reported for 2022 q3
SEC form 10
2022-11-01 00:00 ET
Laboratory of America reported for 2022 q3
SEC form 6
2022-10-31 16:32 ET
Laboratory of America published news for 2022 q3
SEC form 6
2022-10-27 07:06 ET
Laboratory of America published news for 2022 q3
SEC form 8
2022-10-27 00:00 ET
Laboratory of America reported for 2022 q3
SEC form 6
2022-10-13 16:49 ET
Laboratory of America published news for 2022 q3
SEC form 6
2022-10-12 17:10 ET
Laboratory of America published news for 2022 q3
SEC form 6
2022-10-03 14:43 ET
Laboratory of America published news for 2022 q3
SEC form 6
2022-09-27 08:17 ET
Laboratory of America published news for 2022 q2
SEC form 6
2022-09-06 08:57 ET
Laboratory of America published news for 2022 q2
SEC form 10
2022-08-01 14:31 ET
Laboratory of America reported for 2022 q2
SEC form 10
2022-08-01 00:00 ET
Laboratory of America reported for 2022 q2
SEC form 6
2022-07-28 07:03 ET
Laboratory of America published news for 2022 q2
SEC form 8
2022-07-28 00:00 ET
Laboratory of America reported for 2022 q2
SEC form 6
2022-07-14 18:08 ET
Laboratory of America published news for 2022 q2
SEC form 6
2022-07-14 17:08 ET
Laboratory of America published news for 2022 q2
SEC form 6
2022-05-17 12:05 ET
Laboratory of America published news for 2022 q1
SEC form 6
2022-05-13 17:48 ET
Laboratory of America published news for 2022 q1
SEC form 6
2022-05-04 13:39 ET
Laboratory of America published news for 2022 q1
SEC form 10
2022-04-29 11:55 ET
Laboratory of America reported for 2022 q1
SEC form 10
2022-04-29 00:00 ET
Laboratory of America reported for 2022 q1
SEC form 6
2022-04-28 07:14 ET
Laboratory of America published news for 2022 q1
SEC form 8
2022-04-28 00:00 ET
Laboratory of America reported for 2022 q1
SEC form 6
2022-04-07 08:38 ET
Laboratory of America published news for 2022 q1
SEC form 6
2022-03-31 17:02 ET
Laboratory of America published news for 2021 q4
SEC form 6
2022-03-28 16:22 ET
Laboratory of America published news for 2021 q4
SEC form 10
2022-02-25 14:26 ET
Laboratory of America published news for 2021 q4
SEC form 10
2022-02-25 00:00 ET
Laboratory of America published news for 2021 q4
SEC form 6
2022-02-10 07:09 ET
Laboratory of America reported for 2021 q4
SEC form 8
2022-02-10 00:00 ET
Laboratory of America published news for 2021 q4
SEC form 6
2022-02-09 16:59 ET
Laboratory of America published news for 2021 q4
SEC form 6
2022-01-10 16:54 ET
Laboratory of America published news for 2021 q4
SEC form 6
2022-01-05 12:20 ET
Laboratory of America published news for 2021 q4
SEC form 6
2021-12-14 07:08 ET
Laboratory of America published news for 2021 q3
SEC form 6
2021-12-09 07:07 ET
Laboratory of America published news for 2021 q3
SEC form 6
2021-11-02 16:40 ET
Laboratory of America published news for 2021 q3
SEC form 10
2021-11-02 14:46 ET
Laboratory of America published news for 2021 q3
SEC form 10
2021-11-02 00:00 ET
Laboratory of America published news for 2021 q3
SEC form 6
2021-10-28 08:59 ET
Laboratory of America reported for 2021 q3
SEC form 8
2021-10-28 00:00 ET
Laboratory of America published news for 2021 q3
SEC form 6
2021-09-28 16:38 ET
Laboratory of America published news for 2021 q2
SEC form 6
2021-09-13 16:39 ET
Laboratory of America published news for 2021 q2
SEC form 6
2021-09-08 16:24 ET
Laboratory of America published news for 2021 q2
SEC form 6
2021-08-12 21:37 ET
Laboratory of America published news for 2021 q2
SEC form 10
2021-08-05 12:57 ET
Laboratory of America published news for 2021 q2
SEC form 10
2021-08-05 00:00 ET
Laboratory of America published news for 2021 q2
SEC form 6
2021-07-29 08:36 ET
Laboratory of America published news for 2021 q2
SEC form 8
2021-07-29 00:00 ET
Laboratory of America published news for 2021 q2
SEC form 6
2021-07-02 15:57 ET
Laboratory of America published news for 2021 q2
SEC form 6
2021-05-26 17:04 ET
Laboratory of America published news for 2021 q1
SEC form 6
2021-05-18 08:50 ET
Laboratory of America published news for 2021 q1
SEC form 6
2021-05-14 16:08 ET
Laboratory of America published news for 2021 q1
SEC form 6
2021-05-13 18:38 ET
Laboratory of America published news for 2021 q1
SEC form 6
2021-05-12 09:54 ET
Laboratory of America published news for 2021 q1
SEC form 10
2021-05-04 15:54 ET
Laboratory of America published news for 2021 q1
SEC form 6
2021-04-29 08:42 ET
Laboratory of America published news for 2021 q1
SEC form 8
2021-04-29 00:00 ET
Laboratory of America published news for 2021 q1
SEC form 6
2021-04-16 08:59 ET
Laboratory of America published news for 2021 q1
SEC form 6
2021-04-02 09:01 ET
Laboratory of America published news for 2021 q1
SEC form 6
2021-03-31 08:34 ET
Laboratory of America published news for 2020 q4
SEC form 6
2021-03-30 16:40 ET
Laboratory of America published news for 2020 q4
SEC form 6
2021-03-26 07:37 ET
Laboratory of America published news for 2020 q4
SEC form 6
2021-03-19 07:10 ET
Laboratory of America published news for 2020 q4
SEC form 6
2021-03-03 13:38 ET
Laboratory of America published news for 2020 q4
SEC form 10
2021-02-25 15:19 ET
Laboratory of America published news for 2020 q4
SEC form 6
2021-02-23 07:00 ET
Laboratory of America published news for 2020 q4
SEC form 6
2021-02-11 07:04 ET
Laboratory of America published news for 2020 q4
SEC form 6
2021-01-08 07:03 ET
Laboratory of America published news for 2020 q4
SEC form 6
2021-01-05 07:08 ET
Laboratory of America published news for 2020 q4
SEC form 6
2020-11-25 07:05 ET
Laboratory of America published news for 2020 q3
SEC form 6
2020-11-05 17:26 ET
Laboratory of America published news for 2020 q3
SEC form 6
2020-11-02 07:05 ET
Laboratory of America published news for 2020 q3
SEC form 10
2020-10-29 09:54 ET
Laboratory of America published news for 2020 q3
SEC form 6
2020-10-27 06:49 ET
Laboratory of America published news for 2020 q3